Ignite Creation Date:
2024-05-06 @ 7:01 PM
Last Modification Date:
2024-10-26 @ 2:58 PM
Study NCT ID:
NCT05863871
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-05-18
First Post:
2023-05-09
Brief Title:
Real World Study of Linperlisib for Lymphoma Treatment
Sponsor:
Ruijin Hospital
Organization:
Ruijin Hospital
Study Overview
Official Title:
Real World Study of Linperlisib for Lymphoma Treatment Multicenter Non-interventional and Observational Real-world Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MA-LYM-RWS-001
Brief Summary:
This is a multicenter non-interventional and observational real-world study to evaluate the efficacy and safety of linperlisib in patients with lymphoma
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None